查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1618265

血管貼片:市場洞察·競爭環境·市場預測 (～2030年)

Vascular Patches - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

在 2024 年至 2030 年的預測期內，血管補片市場規模預計將以 7.37% 的複合年增長率成長。

由於心房顫動和冠狀動脈疾病(CAD) 等心血管疾病等慢性疾病的增加，以及向血管內治療的轉變、各種血管補片的可用性以及主要技術的創新，血管補片市場正在增長。

血管貼片：市場動態

根據《世界心臟報告（2023）》提供的數據，2021年全球將有超過5億人罹患心血管疾病。此外，根據美國心臟協會（2023）最新提供的數據，預計到2030年，全球將有超過1,200萬人受到心房顫動的影響。

根據英國心臟基金會的全球心臟和循環疾病情況說明書（2024 年），全球約有 2 億人患有 CAD。血管補片在動脈修復、動脈內膜切除術和動脈瘤重建等手術中發揮重要作用，可改善治療效果並最大程度地減少併發症，使其成為現代心血管治療的重要組成部分。

按血管貼片的材料類型劃分，生物血管貼片領域預計將在 2023 年顯示出較大的收入佔有率。該產品類別的快速增長歸因於與合成替代品相比優越的生物相容性、降低的免疫原性以及改善的長期治療結果。

此外，去細胞和交聯等組織加工技術的進步提高了生物貼片的耐用性和安全性，使其更適合複雜的血管手術。由於血管疾病的日益普及以及對天然、反應性較低的植入材料的日益偏愛，生物血管補片越來越受到外科醫生的歡迎，特別是那些具有高性能和低併發症的應用。

本報告提供全球血管貼片的市場調查，彙整市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

目錄

第1章 血管貼片市場報告:簡介

  • 調查範圍
  • 市場分類
  • 市場估計

第2章 血管貼片市場:摘要整理

  • 市場概要

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 血管貼片市場:主要要素分析

  • 推動市場要素
    • 慢性心血管疾病增加
    • 增加產品開發活動
    • 轉向血管內治療
    • 提供多種血管補片
  • 市場限制與挑戰
    • 可供選擇的替代方案
    • 嚴格的監理審批流程
  • 市場機會
    • 膠原蛋白、合成聚合物和生物可吸收血管貼片等先進材料的開發
    • 擴大血管補片在動脈瘤修復的應用

第6章 血管貼片市場:波特的五力分析

第7章 血管貼片市場評估

  • 各材料類型
    • 生物學的血管貼片
    • 合成血管貼片
  • 各用途
    • 頸動脈內薄膜切除術
    • 主動脈瘤
    • 深部形成術
    • 其他
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 血管貼片市場:企業·產品簡介

  • B. Braun Melsungen AG
  • Baxter
  • Terumo Corporation
  • Edwards Lifesciences Corporation
  • W. L. Gore & Associates, Inc.
  • CryoLife, Inc
  • Aziyo
  • Medtrade Products Ltd
  • Collagen Solutions Plc
  • FOC Medical S.A.
  • Anteris
  • Medtronic
  • Labcor Laboratorios
  • BD
  • Johnson & Johnson Services, Inc.
  • Axio Biosolutions

第9章 計劃方法

第10章 關於DelveInsight

第11章 免責聲明·聯絡方式

Product Code: DIMDCL0390

Vascular Patches Market by Material Type (Biologic Vascular Patches and Synthetic Vascular Patches), Application Type (Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, and Others), End-User (Hospital, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing instances of chronic cardiovascular conditions, rising product developmental activities globally

The vascular patches market is estimated to grow at a CAGR of 7.37% during the forecast period from 2024 to 2030. The vascular patches market is growing significantly due to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation, coronary artery disease (CAD) with growing shift toward endovascular treatments, availability of a wide range of vascular patches, and innovative product developmental activities by leading companies that are expected to escalate the demand for vascular patches during the forecast period from 2024 to 2030.

Vascular Patches Market Dynamics:

As per data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally. Further, according to recent data provided by the American Heart Association (2023), it is estimated that by 2030 over 12 million people will have atrial fibrillation globally.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are living with CAD around the world. Vascular patches play a vital role in procedures like arterial repairs, endarterectomy, and aneurysm reconstruction, offering improved outcomes and minimizing complications, making them indispensable in contemporary cardiovascular treatments. Hence the market for the same is increasing.

Increased product developmental activities by market key players across the globe is further expected to drive the market growth for vascular patches. For example, in May 2024, the consortium of Teijin Limited, Fukui Tateami Co., Ltd., and Osaka Medical and Pharmaceutical University announced that, SYNFOLIUM(R) a novel cardiovascular surgical patch, designed with a knitted fabric composed of both bio-absorbable and non-absorbable yarns, coated with cross-linked gelatin was scheduled for manufacturing and distribution from June 2024.

Therefore, the factors stated above collectively will drive the overall vascular patches market during the forecast period from 2024 to 2030.

However, availability of alternative options, stringent regulatory approval process, and others may limit their end-user base, thus acting as key constraints limiting the growth of the vascular patches.

Vascular Patches Market Segment Analysis:

Vascular Patches Market by Material Type (Biologic Vascular Patches and Synthetic Vascular Patches), Application Type (Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, and Others), End-User (Hospital, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the material type segment of vascular patches, the biologic vascular patch category is expected to have a significant revenue share in the year 2023. The rapid growth of this product category is growing due to its superior biocompatibility, reduced immunogenicity, and enhanced long-term outcomes compared to synthetic alternatives.

Biologic patches, derived from materials like bovine pericardium or porcine-derived tissues, offer excellent tissue integration and remodeling properties, minimizing complications such as thrombosis, calcification, or infection. Their natural structure supports endothelialization, which is critical for vascular healing and maintaining patency in arterial and venous reconstructions.

Additionally, advancements in tissue processing techniques, such as decellularization and crosslinking, have improved the durability and safety profiles of biologic patches, making them more suitable for complex vascular procedures. With the increasing prevalence of vascular diseases and a growing preference for natural and less reactive implant materials, biologic vascular patches are becoming a preferred choice among surgeons, especially in applications requiring high performance and minimal complications.

Therefore, owing to all the above-mentioned factors, the demand for the biologic vascular patch category is expected to witness considerable growth eventually contributing to the overall growth of the vascular patches market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall vascular patches market:

Among all the regions, North America is expected to dominate the vascular patches market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. The increasing prevalence of cardiovascular conditions such as coronary artery disease (CAD), myocardial infarction, and peripheral artery disease (PAD), along with rising comorbidities like hypertension and hyperlipidemia, combined with significant advancements in product development and regulatory approvals, and the presence of well- established and sophisticated infrastructure is expected to drive the market for vascular patches during the forecast period from 2024 to 2030.

As per data provided by the National Institute of Health (2023), it stated that 20.5 million people in the US were living with CAD. Furthermore, according to data from the Centers for Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. Furthermore, as per the same source, it was stated that heart disease is an umbrella term that encompasses numerous indications such as acute coronary syndrome, atherosclerosis, and congestive heart failure, among others. Some of the key risk factors associated with heart diseases are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of Americans (47%) have at least one of these three risk factors.

According to data from the Canadian Institute for Health Information (2024), it stated that in 2022, 2.4 million Canadians were affected by heart disease.

As per data from the American Heart Association, 2021, PAD affected about 8.5 million U.S. adults over the age of 40, in 2021. As per the same source, African Americans are more likely to screen positive for PAD than non-Hispanic adults.

Vascular patches are critical in surgical interventions, offering improved vessel repair, reduced complications, and enhanced long-term outcomes, thereby bolstering the market for same.

Rising product launches and commercialization agreements among key manufacturers and other companies are anticipated to boost the market. For instance, in June 2021, Axio Biosolutions announced FDA 510(k) clearance of its hemostatic product Axiostat Patch, which helps control moderate to severe bleeding in vascular procedures.

Therefore, the interplay of all the aforementioned factors above would provide a conducive growth environment for the North American region in the vascular patches market.

Vascular Patches Market key players:

Some of the key market players operating in the vascular patches market include B. Braun Melsungen AG, Baxter, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates, Inc., CryoLife, Inc, Aziyo, Medtrade Products Ltd, Collagen Solutions Plc, FOC Medical S.A., Anteris, Medtronic, Labcor Laboratorios, BD, Johnson & Johnson Services, Inc., Axio Biosolutions, and others.

Recent Developmental Activities in the Vascular Patches Market:

  • In August 2024, Haemonetics fully launched the Vascade MVP XL Vascular Closure System, featuring collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.
  • In September 2021, Terumo Corporation announced the launch of global surgical graft study known as PANTHER, which is a prospective and retrospective study of a comprehensive range of knitted and woven surgical grafts and cardiovascular patches.

Key Takeaways from the Vascular Patches Market Report Study

  • Market size analysis for current vascular patches market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the vascular patches market
  • Various opportunities available for the other competitors in the vascular patches market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current vascular patches market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for vascular patches market growth in the coming future?

Target audience who can be benefited from this vascular patches Market Report Study

  • Vascular patches product providers
  • Research organizations and consulting companies
  • Vascular patches-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in vascular patches
  • Various end-users who want to know more about the vascular patches market and the latest developments in the vascular patches market

Frequently Asked Questions for the Vascular Patches Market:

1. What are vascular patches?

  • The vascular patches, are the patches that are broadly used in blood vessel repair and reconstruction and when blood vessels are severely compromised in cardiovascular diseases, infection, and/or in transplantation. Patches are is characterized by excellent biocompatibility and proven long-term mechanical stability.

2. What is the market for vascular patches?

  • The Vascular Patches market is estimated to grow at a CAGR of 7.37% during the forecast period from 2024 to 2030.

3. What are the drivers for the vascular patches market?

  • The vascular patches market is growing significantly due to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation, coronary artery disease (CAD) with growing shift toward endovascular treatments, availability of wide range of vascular patches, and innovative product developmental activities by leading companies that are expected to escalate the demand for vascular patches during the forecast period from 2024 to 2030.

4. Who are the key players operating in the vascular patches market?

  • Some of the key market players operating in the vascular patches market include B. Braun Melsungen AG, Baxter, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates, Inc., CryoLife, Inc, Aziyo, Medtrade Products Ltd, Collagen Solutions Plc, FOC Medical S.A., Anteris, Medtronic, Labcor Laboratorios, BD, Johnson & Johnson Services, Inc., Axio Biosolutions, and others.

5. Which region has the highest share in the vascular patches market?

  • Among all the regions, North America is estimated to hold a significant revenue share in the vascular patches market. The increasing prevalence of cardiovascular conditions such as coronary artery disease (CAD), myocardial infarction, and peripheral artery disease (PAD), along with rising comorbidities like hypertension and hyperlipidemia, combined with significant advancements in product development and regulatory approvals, and the presence of well- established and sophisticated infrastructure is expected to drive the market for vascular patches during the forecast period from 2024 to 2030.

Table of Contents

1. Vascular Patches Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Vascular Patches Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Vascular Patches Market Key Factors Analysis

  • 5.1. Vascular Patches Market Drivers
    • 5.1.1. Increasing instances of chronic cardiovascular conditions
    • 5.1.2. Rising product developmental activities
    • 5.1.3. Growing shift toward endovascular treatments
    • 5.1.4. Availability of a wide range of vascular patches
  • 5.2. Vascular Patches Market Restraints and Challenges
    • 5.2.1. Availability of alternative options
    • 5.2.2. Stringent regulatory approval process
  • 5.3. Vascular Patches Market Opportunities
    • 5.3.1. Development of advanced materials like collagen, synthetic polymers, or bioabsorbable Vascular Patches
    • 5.3.2. Expanding the use of vascular patches in aneurysm repairs

6. Vascular Patches Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Vascular Patches Market Assessment

  • 7.1. By Material Type
    • 7.1.1. Biologic Vascular Patches
    • 7.1.2. Synthetic Vascular Patches
  • 7.2. By Application Type
    • 7.2.1. Carotid Endarterectomy
    • 7.2.2. Aortic Aneurysms
    • 7.2.3. Profundaplasty
    • 7.2.4. Others
  • 7.3. By End-User
    • 7.3.1. Hospital
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.1.2. Canada Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Vascular Patches Market Size in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.2.5. Spain Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Vascular Patches Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.3.3. India Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Vascular Patches Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.4.2. Africa Vascular Patches Market Size in USD million (2021-2030)
      • 7.4.4.3. South America Vascular Patches Market Size in USD million (2021-2030)

8. Vascular Patches Market Company and Product Profiles

  • 8.1. B. Braun Melsungen AG
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Baxter
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Terumo Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Edwards Lifesciences Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. W. L. Gore & Associates, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. CryoLife, Inc
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Aziyo
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Medtrade Products Ltd
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Collagen Solutions Plc
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. FOC Medical S.A.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Anteris
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Medtronic
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Labcor Laboratorios
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. BD
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Johnson & Johnson Services, Inc.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Axio Biosolutions
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Vascular Patches Market in Global (2021-2030)
  • Table 3: Vascular Patches Market in Global by Material Type (2021-2030)
  • Table 4: Vascular Patches Market in Global by Application Type (2021-2030)
  • Table 5: Vascular Patches Market in Global by End-User (2021-2030)
  • Table 6: Vascular Patches Market in Global by Geography (2021-2030)
  • Table 7: Vascular Patches Market in North America (2021-2030)
  • Table 8: Vascular Patches Market in the United States (2021-2030)
  • Table 9: Vascular Patches Market in Canada (2021-2030)
  • Table 10: Vascular Patches Market in Mexico (2021-2030)
  • Table 11: Vascular Patches Market in Europe (2021-2030)
  • Table 12: Vascular Patches Market in France (2021-2030)
  • Table 13: Vascular Patches Market in Germany (2021-2030)
  • Table 14: Vascular Patches Market in United Kingdom (2021-2030)
  • Table 15: Vascular Patches Market in Italy (2021-2030)
  • Table 16: Vascular Patches Market in Spain (2021-2030)
  • Table 17: Vascular Patches Market in the Rest of Europe (2021-2030)
  • Table 18: Vascular Patches Market in Asia-Pacific (2021-2030)
  • Table 19: Vascular Patches Market in China (2021-2030)
  • Table 20: Vascular Patches Market in Japan (2021-2030)
  • Table 21: Vascular Patches Market in India (2021-2030)
  • Table 22: Vascular Patches Market in Australia (2021-2030)
  • Table 23: Vascular Patches Market in South Korea (2021-2030)
  • Table 24: Vascular Patches Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Vascular Patches Market in the Rest of the World (2021-2030)
  • Table 26: Vascular Patches Market in the Middle East (2021-2030)
  • Table 27: Vascular Patches Market in Africa (2021-2030)
  • Table 28: Vascular Patches Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Vascular Patches Market in Global (2021-2030)
  • Figure 3: Vascular Patches Market in Global by Material Type (2021-2030)
  • Figure 4: Vascular Patches Market in Global by Application Type (2021-2030)
  • Figure 5: Vascular Patches Market in Global by End-User (2021-2030)
  • Figure 6: Vascular Patches Market in Global by Geography (2021-2030)
  • Figure 7: Vascular Patches Market in North America (2021-2030)
  • Figure 8: Vascular Patches Market in the United States (2021-2030)
  • Figure 9: Vascular Patches Market in Canada (2021-2030)
  • Figure 10: Vascular Patches Market in Mexico (2021-2030)
  • Figure 11: Vascular Patches Market in Europe (2021-2030)
  • Figure 12: Vascular Patches Market in France (2021-2030)
  • Figure 13: Vascular Patches Market in Germany (2021-2030)
  • Figure 14: Vascular Patches Market in United Kingdom (2021-2030)
  • Figure 15: Vascular Patches Market in Italy (2021-2030)
  • Figure 16: Vascular Patches Market in Spain (2021-2030)
  • Figure 17: Vascular Patches Market in the Rest of Europe (2021-2030)
  • Figure 18: Vascular Patches Market in Asia-Pacific (2021-2030)
  • Figure 19: Vascular Patches Market in China (2021-2030)
  • Figure 20: Vascular Patches Market in Japan (2021-2030)
  • Figure 21: Vascular Patches Market in India (2021-2030)
  • Figure 22: Vascular Patches Market in Australia (2021-2030)
  • Figure 23: Vascular Patches Market in South Korea (2021-2030)
  • Figure 24: Vascular Patches Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Vascular Patches Market in the Rest of the World (2021-2030)
  • Figure 26: Vascular Patches Market in the Middle East (2021-2030)
  • Figure 27: Vascular Patches Market in Africa (2021-2030)
  • Figure 28: Vascular Patches Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis